WILLIAM CHRISTOPHER GARRE

Allopathic & Osteopathic Physicians|Family Medicine CHANDLER, TX NPI 1275980948

General Payments — all program years on this page

$1,522.41

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 78
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $391.07 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $391.0721

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $178.975
2020 $32.142
2021 $221.6412
2022 $290.9214
2023 $407.6724
2024 $391.0721

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086932299 Novartis Pharmaceuticals Corporation $19.20 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086932323 Novartis Pharmaceuticals Corporation $19.24 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089516742 Currax Pharmaceuticals LLC $16.32 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097199847 Novo Nordisk Inc $24.55 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777987 ABBVIE INC. $9.20 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777989 ABBVIE INC. $18.42 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777991 ABBVIE INC. $10.51 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777993 ABBVIE INC. $21.52 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777995 ABBVIE INC. $12.84 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777997 ABBVIE INC. $16.16 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103777999 ABBVIE INC. $22.09 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103778001 ABBVIE INC. $25.26 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103778003 ABBVIE INC. $14.11 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105212525 AstraZeneca Pharmaceuticals LP $17.00 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116401557 GlaxoSmithKline, LLC. $14.20 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116446982 GlaxoSmithKline, LLC. $19.57 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116466594 GlaxoSmithKline, LLC. $13.20 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135453385 Lilly USA, LLC $17.46 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137552662 Takeda Pharmaceuticals U.S.A., Inc. $15.27 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147970256 ACADIA Pharmaceuticals Inc $32.47 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147970258 ACADIA Pharmaceuticals Inc $32.48 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.